14-3-3 ζ Overexpression is Associated with Poor Prognosis in Ovarian Cancer.
CONCLUSION: 14-3-3ζoverexpression might be a potential prognostic biomarker for ovarian cancer, and the inhibition of 14-3-3ζcould be a therapeutic option that enhances the antitumor activity of cisplatin.
PMID: 29214776 [PubMed - in process]
Source: Yonsei Medical Journal - Category: Universities & Medical Training Authors: Kim HJ, Sung SH, Kim CY, Bae MK, Cho MS, Kim YH, Kim SC, Ju W Tags: Yonsei Med J Source Type: research